journal article·2024-02-20Open access

Toxicity Assessment of New Ag-ZnO/AgO Nanocomposites: An In Vitro and In Vivo Approach

José Rodrigues do Carmo Neto, Pablo Igor Ribeiro Franco, Yarlla Loyane Lira Braga, Jordana Fernandes de Oliveira, Hugo Felix Perini, Luís Fernando Duarte Albuquerque, Danieli Brolo Martins, Fernanda Rodrigues Helmo, Anderson Assunção Andrade, Marina Pacheco Miguel, Mara Rúbia Nunes Celes, Thiago Lopes Rocha, Anielle Christine Almeida Silva, Juliana Reis Machado, Marcos Vinícius da Silva

Abstract

Zinc oxide nanoparticles (ZnO NPs) are metal oxide nanomaterials, which are important for several applications: antibacterial, anthelmintic, antiprotozoal and antitumoral, among others. These applications are mainly related to the ability to spontaneously produce and induce the production of reactive oxygen species that are important components for the destruction of pathogens and tumor cells. While trying to potentiate ZnO NPs, studies have associated these NPs with silver oxide (AgO) or silver (Ag) NPs. It has already been reported that this combination (Ag-ZnO/AgO NPs) is able to enhance the microbicidal potential. Although possessing much potential for several purposes, it is important to evaluate whether this association also poses the risk of toxicity to cells and experimental models. Therefore, this work aimed to evaluate the toxicity of various Ag-ZnO/AgO NP nanocomposites, in vitro and in vivo. Accordingly, ZnO nanocrystals and nanocomposites with various concentrations of AgO (ZnO:5Ag, ZnO:9Ag or ZnO:11Ag) were used in different cytotoxicity models: Galleria mellonella (G. mellonella), cell lines (VERO and RAW 264.7) and C57BL/6 mice. In the G. mellonella model, four concentrations were used in a single dose, with subsequent evaluation of mortality. In the case of cells, serial concentrations starting at 125 µg/mL were used, with subsequent cytotoxicity assessment. Based on the safe doses obtained in G. mellonella and cell models, the best doses were used in mice, with subsequent evaluations of weight, biochemistry as also renal and liver histopathology. It was observed that the toxicity, although low, of the nanocomposites was dependent upon the concentration of AgO used in association with ZnO NPs, both in vitro and in vivo.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiânia 74605-050, GO, Brazil

Department of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil

Programa de Pós-Graduação em Ciências Animal, School of Veterinary and Animal Science, Federal University of Goias, Goiânia 74690-900, GO, Brazil

Department of General Pathology, Federal University of Triângulo Mineiro, Uberaba 38025-180, MG, Brazil

Laboratory of Environmental Biotechnology and Ecotoxicology, Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia 74605-050, GO, Brazil

Laboratório de Novos Materiais Nanoestruturados e Funcionais (LNMIS), Physics Institute, Federal University of Alagoas, Maceió 57072-900, AL, Brazil

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior · Conselho Nacional de Desenvolvimento Científico e Tecnológico · Fundação de Amparo à Pesquisa do Estado Minas Gerais

References (44)

Show source-provided references
1. Zinc oxide nanoparticles impacts: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity10.1080/15376516.2018.1553221 ↗
2. Cytotoxicity of Metal-Based Nanoparticles: From mechanisms and methods of evaluation to pathological manifestations10.1002/advs.202106049 ↗
3. Zinc oxide nanoparticles: A promising nanomaterial for biomedical applications10.1016/j.drudis.2017.08.006 ↗
4. Relationship Between Structure and Antimicrobial Activity of Zinc Oxide Nanoparticles: An Overview10.2147/IJN.S216204 ↗
5. ZnO nanoparticle tracking from uptake to genotoxic damage in human colon carcinoma cells10.1016/j.tiv.2016.06.005 ↗
6. Antiprotozoal and Anthelmintic Activity of Zinc Oxide Nanoparticles10.2174/0929867328666210709105850 ↗
7. Biologically-synthesised ZnO/CuO/Ag nanocomposite using propolis extract and coated on the gauze for wound healing applications10.1049/iet-nbt.2020.0024 ↗
8. Enhanced wound healing activity of Ag-ZnO composite NPs in Wistar Albino rats10.1049/iet-nbt.2017.0087 ↗
9. Fonseca, B.B., Silva, P.L.A.P.A., Silva, A.C.A., Dantas, N.O., de Paula, A.T., Olivieri, O.C.L., Beletti, M.E., Rossi, D.A., and Goulart, L.R. (2019). Nanocomposite of Ag-Doped ZnO and AgO Nanocrystals as a Preventive Measure to Control Biofilm Formation in Eggshell and Salmonella spp. Entry Into Eggs. Front. Microbiol., 19.10.3389/fmicb.2019.00217 ↗
10. Barbosa, R.M., Obata, M.M.S., Neto, J.R.D.C., Guerra, R.O., Borges, A.V.B.E., Trevisan, R.O., Ruiz, L.C., Bernardi, J.M., Oliveira-Scussel, A.C.M., and Vaz Tanaka, S.C.S. (2022). Development of Ag-ZnO/AgO Nanocomposites Effectives for Leishmania braziliensis Treatment. Pharmaceutics, 14.10.3390/pharmaceutics14122642 ↗
11. Antioxidant, anti-inflammatory, and wound healing effects of topical silver-doped zinc oxide and silver oxide nanocomposites10.1016/j.ijpharm.2022.121620 ↗
12. Müller, R., and Lloyd, R. (1994). Sublethal and Chronic Effects of Pollutants on Freshwater Fish, Fishing News Books.
13. Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: A systemic toxicity assay10.1007/s13277-014-2966-x ↗
14. The toxicity of ZnO nanomaterials to HepG2 cells: The influence of size and shape of particles10.1002/jat.3712 ↗
15. Comparison of cytotoxicity of Ag/ZnO and Ag@ZnO nanocomplexes to human umbilical vein endothelial cells in vitro10.1002/jat.4125 ↗
16. Combined effects of low levels of palmitate on toxicity of ZnO nanoparticles to THP-1 macrophages10.1016/j.etap.2016.10.014 ↗
17. Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling10.1016/j.tiv.2013.12.004 ↗
18. Assessment of the genotoxic potential of two zinc oxide sources (amorphous and nanoparticles) using the in vitro micronucleus test and the in vivo wing somatic mutation and recombination test10.1016/j.fct.2015.07.008 ↗
19. Elje, E., Mariussen, E., Moriones, O.H., Bastús, N.G., Puntes, V., Kohl, Y., Dusinska, M., and Rundén-Pran, E. (2020). Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model. Nanomaterials, 10.10.3390/nano10030545 ↗
20. A systematic review on silver nanoparticles-induced cytotoxicity: Physicochemical properties and perspectives
21. Mechanisms of toxic action of Ag, ZnO and CuO nanoparticles to selected ecotoxicological test organisms and mammalian cells in vitro: A comparative review10.3109/17435390.2013.855831 ↗
22. Zinc oxide nanoparticles: Synthesis, antiseptic activity and toxicity mechanism10.1016/j.cis.2017.07.033 ↗
23. Molecular toxicity mechanism of nanosilver10.1016/j.jfda.2014.01.010 ↗
24. Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism
25. Antibacterial properties and toxicity from metallic nanomaterials10.2147/IJN.S134526 ↗
26. Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice10.3109/15376516.2013.764950 ↗
27. Drobne, D., Novak, S., Talaber, I., Lynch, I., and Kokalj, A.J. (2018). The Biological Fate of Silver Nanoparticles from a Methodological Perspective. Materials, 11.10.3390/ma11060957 ↗
28. Ferdous, Z., and Nemmar, A. (2020). Health Impact of Silver Nanoparticles: A Review of the Biodistribution and Toxicity Following Various Routes of Exposure. Int. J. Mol. Sci., 21.10.3390/ijms21072375 ↗
29. The effect of fluorination of zinc oxide nanoparticles on evaluation of their biodistribution after oral administration10.1088/0957-4484/23/20/205102 ↗
30. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice10.3109/17435390.2011.620717 ↗
31. Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo10.1039/c3nr02140h ↗
32. A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles
33. Sex affects the response of Wistar rats to polyvinyl pyrrolidone (PVP)-coated silver nanoparticles in an oral 28 days repeated dose toxicity study10.1186/s12989-021-00425-y ↗
34. Biodistribution and organ oxidative damage following 28 days oral administration of nanosilver with/without coating in mice10.1002/jat.3946 ↗
35. Hepatotoxic Effect of Oral Zinc Oxide Nanoparticles and the Ameliorating Role of Selenium in Rats: A histological, immunohistochemical and molecular study10.1016/j.tice.2020.101441 ↗
36. Hepatic histopathological and ultrastructural alterations induced by 10 nm silver nanoparticles10.1049/iet-nbt.2020.0039 ↗
37. Zinc oxide nanoparticles hepatotoxicity: Histological and histochemical study10.1016/j.etap.2017.02.015 ↗
38. The role of hypoxia-inducible factor-1α in zinc oxide nanoparticle-induced nephrotoxicity in vitro and in vivo10.1186/s12989-016-0163-3 ↗
39. Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats10.1080/10934529.2012.650576 ↗
40. Size-dependent acute toxicity of silver nanoparticles in mice10.1293/tox.2017-0043 ↗
41. Size dependent effect of ZnO nanoparticles on endoplasmic reticulum stress signaling pathway in murine liver10.1016/j.jhazmat.2016.05.063 ↗
42. Comparative study of zinc oxide nanoparticles and its bulk form on liver function of Wistar rat10.1177/0748233719878970 ↗
43. Factors influencing the cytotoxicity of zinc oxide nanoparticles: Particle size and surface charge10.1088/1742-6596/304/1/012044 ↗
44. Review of Zinc Oxide Nanoparticles: Toxicokinetics, Tissue Distribution for Various Exposure Routes, Toxicological Effects, Toxicity Mechanism in Mammals, and an Approach for Toxicity Reduction10.1007/s12011-023-03644-w ↗